The role of innate immune cells in obese adipose tissue inflammation and development of insulin resistance

Thrombosis and Haemostasis

Volumn 109, Issue 3, 2013, Pages 399-406

  Chmelar, Jindrich ^a,b   Chung, Kyoung Jin ^a   Chavakis, Triantafyllos ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b INSTITUTE OF PARASITOLOGY   (Czech Republic)

Author keywords

Adipose tissue; Inflammation; Leukocytes; Obesity; Review

Indexed keywords

CD11B ANTIGEN; CD1C ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; DIPEPTIDYL PEPTIDASE IV; GAMMA INTERFERON; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN KINASE; STAT6 PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR;

ADIPOSE TISSUE INFLAMMATION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EOSINOPHIL; HEMOSTASIS; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; INSULIN RESISTANCE; LEUKOCYTE; MACROPHAGE; MAST CELL; METABOLIC SYNDROME X; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; OBESITY; PRIORITY JOURNAL;

ADIPOSE TISSUE; ANIMALS; DENDRITIC CELLS; EOSINOPHILS; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; INFLAMMATION; INSULIN RESISTANCE; KILLER CELLS, NATURAL; LEUKOCYTES; LYMPHOCYTE SUBSETS; MACROPHAGES; MAST CELLS; NEUTROPHILS; OBESITY;

EID: 84874781588     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-09-0703     Document Type: Article

References (104)

1. Gustafson B. Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb 2010; 17: 332-341.
2. Gustafson B, Hammarstedt A, Andersson CX, et al. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27: 2276-2283.
3. Cornier MA, Dabelea D, Hernandez TL, et al. The metabolic syndrome. Endocr Rev 2008; 29: 777-822.
4. Chawla A, Nguyen KD, Goh YP. Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol 2011; 11: 738-749.
5. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011; 11: 98-107.
6. Yudkin JS, Stehouwer CD, Emeis JJ, et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972-978.
7. Despres JP, Lemieux I, Bergeron J, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008; 28: 1039-1049.
8. Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010; 140: 900-917.
9. Hoene M, Weigert C. The role of interleukin-6 in insulin resistance, body fat distribution and energy balance. Obes Rev 2008; 9: 20-29.
10. Uysal KT, Wiesbrock SM, Marino MW, et al. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997; 389: 610-614.
11. Hotamisligil GS. The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med 1999; 245: 621-625.
12. Chatzigeorgiou A, Karalis KP, Bornstein SR, et al. Lymphocytes in obesity-related adipose tissue inflammation. Diabetologia 2012; 55: 2583-2592.
13. Elgazar-Carmon V, Rudich A, Hadad N, et al. Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding. J Lipid Res 2008; 49: 1894-1903.
14. Liu J, Divoux A, Sun J, et al. Genetic deficiency and pharmacological stabilisation of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med 2009; 15: 940-945.
15. Talukdar S, Oh DY, Bandyopadhyay G, et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med 2012; epub ahead of print.
16. Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
17. van Oostrom AJ, Rabelink TJ, Verseyden C, et al. Activation of leukocytes by postprandial lipemia in healthy volunteers. Atherosclerosis 2004; 177: 175-182.
18. Mohanty P, Hamouda W, Garg R, et al. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 2000; 85: 2970-2973.
19. Wentworth JM, Naselli G, Brown WA, et al. Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 2010; 59: 1648-1656.
20. Winer S, Chan Y, Paltser G, et al. Normalisation of obesity-associated insulin resistance through immunotherapy. Nat Med 2009; 15: 921-929.
21. Feuerer M, Herrero L, Cipolletta D, et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 2009; 15: 930-939.
22. Nishimura S, Manabe I, Nagasaki M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009; 15: 914-920.
23. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953-964.
24. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-1830.
25. Chen A, Mumick S, Zhang C, et al. Diet induction of monocyte chemoattractant protein-1 and its impact on obesity. Obes Res 2005; 13: 1311-1320.
26. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarisation. J Clin Invest 2007; 117: 175-184.
27. Lumeng CN, DelProposto JB, Westcott DJ, et al. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 2008; 57: 3239-3246.
28. Westcott DJ, Delproposto JB, Geletka LM, et al. MGL1 promotes adipose tissue inflammation and insulin resistance by regulating 7/4hi monocytes in obesity. J Exp Med 2009; 206: 3143-3156.
29. Lumeng CN, Deyoung SM, Saltiel AR. Macrophages block insulin action in adipocytes by altering expression of signalling and glucose transport proteins. Am J Physiol Endocrinol Metab 2007; 292: E166-174.
30. Shaul ME, Bennett G, Strissel KJ, et al. Dynamic, M2-like remodeling phenotypes of CD11c+ adipose tissue macrophages during high-fat diet--induced obesity in mice. Diabetes 2010; 59: 1171-1181.
31. Patsouris D, Li PP, Thapar D, et al. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 2008; 8: 301-309.
32. Shi H, Kokoeva MV, Inouye K, et al. TLR4 links innate immunity and fatty acidinduced insulin resistance. J Clin Invest 2006; 116: 3015-3025.
33. Saberi M, Woods NB, de Luca C, et al. Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab 2009; 10: 419-429.
34. Pal D, Dasgupta S, Kundu R, et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med 2012; epub ahead of print.
35. Kang K, Reilly SM, Karabacak V, et al. Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarisation and insulin sensitivity. Cell Metab 2008; 7: 485-495.
36. Liao X, Sharma N, Kapadia F, et al. Kruppel-like factor 4 regulates macrophage polarisation. J Clin Invest 2011; 121: 2736-2749.
37. Nguyen KD, Qiu Y, Cui X, et al. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 2011; 480: 104-108.
38. Kanda H, Tateya S, Tamori Y, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006; 116: 1494-1505.
39. Weisberg SP, Hunter D, Huber R, et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006; 116: 115-124.
40. Kirk EA, Sagawa ZK, McDonald TO, et al. Monocyte chemoattractant protein deficiency fails to restrain macrophage infiltration into adipose tissue [corrected]. Diabetes 2008; 57: 1254-1261.
41. Inouye KE, Shi H, Howard JK, et al. Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. Diabetes 2007; 56: 2242-2250.
42. Feral CC, Neels JG, Kummer C, et al. Blockade of alpha4 integrin signalling ameliorates the metabolic consequences of high-fat diet-induced obesity. Diabetes 2008; 57: 1842-1851.
43. Kawano Y, Nakae J, Watanabe N, et al. Loss of Pdk1-Foxo1 signalling in myeloid cells predisposes to adipose tissue inflammation and insulin resistance. Diabetes 2012; 61: 1935-1948.
44. Wu L, Liu YJ. Development of dendritic-cell lineages. Immunity 2007; 26: 741-750.
45. Dominguez PM, Ardavin C. Differentiation and function of mouse monocytederived dendritic cells in steady state and inflammation. Immunol Rev 2011; 234: 90-104.
46. Musilli C, Paccosi S, Pala L, et al. Characterisation of circulating and monocytederived dendritic cells in obese and diabetic patients. Mol Immunol 2011; 49: 234-238.
47. Bertola A, Ciucci T, Rousseau D, et al. Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes 2012; 61: 2238-2247.
48. Stefanovic-Racic M, Yang X, Turner MS, et al. Dendritic cells promote macrophage infiltration and comprise a substantial proportion of obesity-associated increases in CD11c+ cells in adipose tissue and liver. Diabetes 2012; 61: 2330-2339.
49. Zhong J, Rao X, Deiuliis J, et al. A Potential Role for Dendritic Cell/Macrophage-Expressing DPP4 in Obesity-Induced Visceral Inflammation. Diabetes 2012; epub ahead of print.
50. Yekollu SK, Thomas R, O'Sullivan B. Targeting curcusomes to inflammatory dendritic cells inhibits NF-kappaB and improves insulin resistance in obese mice. Diabetes 2012; 60: 2928-2938.
51. Soehnlein O, Zernecke A, Eriksson EE, et al. Neutrophil secretion products pave the way for inflammatory monocytes. Blood 2008; 112: 1461-1471.
52. Gerhardt CC, Romero IA, Cancello R, et al. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol 2001; 175: 81-92.
53. Andrade VL, Petruceli E, Belo VA, et al. Evaluation of plasmatic MMP-8, MMP-9, TIMP-1 and MPO levels in obese and lean women. Clin Biochem 2012; 45: 412-415.
54. Houghton AM, Rzymkiewicz DM, Ji H, et al. Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med 2010; 16: 219-223.
55. Cai TQ, Wright SD. Human leukocyte elastase is an endogenous ligand for the integrin CR3 (CD11b/CD18, Mac-1, alpha M beta 2) and modulates polymorphonuclear leukocyte adhesion. J Exp Med 1996; 184: 1213-1223.
56. Soehnlein O, Weber C, Lindbom L. Neutrophil granule proteins tune monocytic cell function. Trends Immunol 2009; 30: 538-546.
57. Korkmaz B, Horwitz MS, Jenne DE, et al. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev 2010; 62: 726-759.
58. Yvan-Charvet L, Welch C, Pagler TA, et al. Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signalling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation 2008; 118: 1837-1847.
59. Drechsler M, Megens RT, van Zandvoort M, et al. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 2010; 122: 1837-1845.
60. Viardot A, Heilbronn LK, Samocha-Bonet D, et al. Obesity is associated with activated and insulin resistant immune cells. Diabetes Metab Res Rev 2012; 28: 447-454.
61. Kordonowy LL, Burg E, Lenox CC, et al. Obesity is associated with neutrophil dysfunction and attenuation of murine acute lung injury. Am J Respir Cell Mol Biol 2012; 47: 120-127.
62. Hu N, Westra J, Rutgers A, et al. Decreased CXCR1 and CXCR2 expression on neutrophils in anti-neutrophil cytoplasmic autoantibody-associated vasculitides potentially increases neutrophil adhesion and impairs migration. Arthritis Res Ther 2011; 13: R201.
63. Trellakis S, Rydleuskaya A, Fischer C, et al. Low adiponectin, high levels of apoptosis and increased peripheral blood neutrophil activity in healthy obese subjects. Obes Facts 2012; 5: 305-318.
64. Wu D, Molofsky AB, Liang HE, et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011; 332: 243-247.
65. Ricardo-Gonzalez RR, Red Eagle A, Odegaard JI, et al. IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity. Proc Natl Acad Sci USA 2010; 107: 22617-22622.
66. Ji Y, Sun S, Xia S, et al. Short term high fat diet challenge promotes alternative macrophage polarisation in adipose tissue via natural killer T cells and interleukin-J Biol Chem 2012; 287: 24378-24386.
67. Ji Y, Sun S, Xu A, et al. Activation of natural killer T cells promotes M2 Macrophage polarisation in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signalling axis in obesity. J Biol Chem 2012; 287: 13561-13571.
68. Calixto MC, Lintomen L, Schenka A, et al. Obesity enhances eosinophilic inflammation in a murine model of allergic asthma. Br J Pharmacol 2010; 159: 617-625.
69. Kato H, Ueki S, Kamada R, et al. Leptin has a priming effect on eotaxin-induced human eosinophil chemotaxis. Int Arch Allergy Immunol 2011; 155: 335-344.
70. Vieira VJ, Ronan AM, Windt MR, et al. Elevated atopy in healthy obese women. Am J Clin Nutr 2005; 82: 504-509.
71. Maizels RM, Allen JE. Immunology. Eosinophils forestall obesity. Science 2011; 332: 186-187.
72. Gri G, Frossi B, D'Inca F, et al. Mast cell: an emerging partner in immune interaction. Front Immunol 2012; 3: 120.
73. Otsuka A, Kubo M, Honda T, et al. Requirement of interaction between mast cells and skin dendritic cells to establish contact hypersensitivity. PLoS One 2011; 6: e25538.
74. Irani AA, Schechter NM, Craig SS, et al. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 1986; 83: 4464-4468.
75. Xu JM, Shi GP. Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases. Endocr Rev 2012; 33: 71-108.
76. Altintas MM, Azad A, Nayer B, et al. Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice. J Lipid Res 2011; 52: 480-488.
77. Altintas MM, Nayer B, Walford EC, et al. Leptin deficiency-induced obesity affects the density of mast cells in abdominal fat depots and lymph nodes in mice. Lipids Health Dis 2012; 11: 21.
78. Altintas MM, Rossetti MA, Nayer B, et al. Apoptosis, mastocytosis, and diminished adipocytokine gene expression accompany reduced epididymal fat mass in long-standing diet-induced obese mice. Lipids Health Dis 2011; 10: 198.
79. Rodewald HR, Feyerabend TB. Widespread immunological functions of mast cells: fact or fiction? Immunity 2012; 37: 13-24.
80. Dudeck A, Dudeck J, Scholten J, et al. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 2012; 34: 973-984.
81. Feyerabend TB, Weiser A, Tietz A, et al. Cre-mediated cell ablation contests mast cell contribution in models of antibody-and T cell-mediated autoimmunity. Immunity 2011; 35: 832-844.
82. Tanaka A, Nomura Y, Matsuda A, et al. Mast cells function as an alternative modulator of adipogenesis through 15-deoxy-delta-12, 14-prostaglandin J2. Am J Physiol Cell Physiol 2011; 301: C1360-1367.
83. Tsuruda T, Kato J, Hatakeyama K, et al. Adventitial mast cells contribute to pathogenesis in the progression of abdominal aortic aneurysm. Circ Res 2008; 102: 1368-1377.
84. Triggiani M, Granata F, Frattini A, et al. Activation of human inflammatory cells by secreted phospholipases A2. Biochim Biophys Acta 2006; 1761: 1289-1300.
85. Company C, Piqueras L, Naim Abu Nabah Y, et al. Contributions of ACE and mast cell chymase to endogenous angiotensin II generation and leucocyte recruitment in vivo. Cardiovasc Res 2011; 92: 48-56.
86. Di Santo JP. Natural killer cell developmental pathways: a question of balance. Annu Rev Immunol 2006; 24: 257-286.
87. Malhotra A, Shanker A. NK cells: immune cross-talk and therapeutic implications. Immunotherapy 2011; 3: 1143-1166.
88. Costantini C, Cassatella MA. The defensive alliance between neutrophils and NK cells as a novel arm of innate immunity. J Leukoc Biol 2011; 89: 221-233.
89. Nieman DC, Henson DA, Nehlsen-Cannarella SL, et al. Influence of obesity on immune function. J Am Diet Assoc 1999; 99: 294-299.
90. Scanga CB, Verde TJ, Paolone AM, et al. Effects of weight loss and exercise training on natural killer cell activity in obese women. Med Sci Sports Exerc 1998; 30: 1666-1671.
91. Guo H, Xu B, Gao L, et al. High frequency of activated natural killer and natural killer T-cells in patients with new onset of type 2 diabetes mellitus. Exp Biol Med (Maywood) 2012; 237: 556-562.
92. Lynch LA, O'Connell JM, Kwasnik AK, et al. Are natural killer cells protecting the metabolically healthy obese patient? Obesity 2009; 17: 601-605.
93. Kelley DS, Daudu PA, Branch LB, et al. Energy restriction decreases number of circulating natural killer cells and serum levels of immunoglobulins in overweight women. Eur J Clin Nutr 1994; 48: 9-18.
94. Duffaut C, Galitzky J, Lafontan M, et al. Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. Biochem Biophys Res Commun 2009; 384: 482-485.
95. Barra NG, Chew MV, Reid S, et al. Interleukin-15 treatment induces weight loss independent of lymphocytes. PLoS One 2012; 7: e39553.
96. Barra NG, Reid S, MacKenzie R, et al. Interleukin-15 contributes to the regulation of murine adipose tissue and human adipocytes. Obesity 2010; 18: 1601-1607.
97. Tian Z, Sun R, Wei H, et al. Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation. Biochem Biophys Res Commun 2002; 298: 297-302.
98. Wrann CD, Laue T, Hubner L, et al. Short-term and long-term leptin exposure differentially affect human natural killer cell immune functions. Am J Physiol Endocrinol Metab 2011; 302: E108-116.
99. Nave H, Mueller G, Siegmund B, et al. Resistance of Janus kinase-2 dependent leptin signalling in natural killer (NK) cells: a novel mechanism of NK cell dysfunction in diet-induced obesity. Endocrinology 2008; 149: 3370-3378.
100. Hayakawa Y, Smyth MJ. Innate immune recognition and suppression of tumors. Adv Cancer Res 2006; 95: 293-322.
101. Schroder K, Tschopp J. The inflammasomes. Cell 2010; 140: 821-832.
102. Stienstra R, Joosten LA, Koenen T, et al. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab 2010; 12: 593-605.
103. Wen H, Gris D, Lei Y, et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signalling. Nat Immunol 2011; 12: 408-415.
104. Vandanmagsar B, Youm YH, Ravussin A, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 2011; 17: 179-188.